|
Volumn 33 Suppl 1, Issue , 2006, Pages 179-183
|
Phase I study of concurrent radiotherapy with S-1 for oral squamous cell carcinoma
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC ANTIMETABOLITE;
OXONIC ACID;
S 1 (COMBINATION);
TEGAFUR;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
DRUG ADMINISTRATION;
DRUG COMBINATION;
FEMALE;
HUMAN;
MALE;
MAXIMUM TOLERATED DOSE;
MIDDLE AGED;
MOUTH TUMOR;
MULTIMODALITY CANCER THERAPY;
NAUSEA;
PHASE 1 CLINICAL TRIAL;
QUALITY OF LIFE;
RADIATION DOSE;
SQUAMOUS CELL CARCINOMA;
STOMATITIS;
ADULT;
AGED;
ANTIMETABOLITES, ANTINEOPLASTIC;
CARCINOMA, SQUAMOUS CELL;
COMBINED MODALITY THERAPY;
DRUG ADMINISTRATION SCHEDULE;
DRUG COMBINATIONS;
FEMALE;
HUMANS;
MALE;
MAXIMUM TOLERATED DOSE;
MIDDLE AGED;
MOUTH NEOPLASMS;
NAUSEA;
OXONIC ACID;
QUALITY OF LIFE;
RADIOTHERAPY DOSAGE;
STOMATITIS;
TEGAFUR;
|
EID: 33747388697
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (0)
|